A C Newland|B T Colvin - JoVE Visualize

Showing results (171-180 of 234) with videos related to

Pageof 24

Sort By:

British Journal of Haematology|October 23, 1997

Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemic cells: a possible novel mechanism of regulating drug resistanceL Jia, P D Allen, M G Macey, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Serum osteocalcin in the management of myelomaA T Williams, M J Shearer, J Oyeyi, et al.

British Journal of Haematology|October 23, 1997

Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cellsL Jia, R R Dourmashkin, P D Allen, et al.

Bone Marrow Transplantation|January 10, 2001

Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferonN C McBride, J D Cavenagh, A C Newland, et al.

Investigational New Drugs|January 1, 1997

Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphomaD S Richardson, S M Kelsey, S A Johnson, et al.

Cancer Research|March 4, 1998

1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2Y L Wu, X R Jiang, D M Lillington, et al.

British Medical Journal (Clinical Research Ed.)|February 12, 1983

Erythrapheresis in patients with polycythaemia secondary to hypoxic lung diseaseJ A Wedzicha, R M Rudd, M C Apps, et al.

Medical Oncology (Northwood, London, England)|December 15, 2000

Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotideM J Jenner, I N Micallef, A Z Rohatiner, et al.

Clinical Science (London, England : 1979)|October 1, 1985

Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemiaJ A Wedzicha, P M Cotes, D W Empey, et al.

Clinical Science (London, England : 1979)|January 1, 1986

Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonaleP J Wallis, J D Skehan, A C Newland, et al.

Pageof 24

Showing results (171-180 of 234) with videos related to

Sort By:

Pageof 24

British Journal of Haematology|October 23, 1997

Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemic cells: a possible novel mechanism of regulating drug resistanceL Jia, P D Allen, M G Macey, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1992

Serum osteocalcin in the management of myelomaA T Williams, M J Shearer, J Oyeyi, et al.

British Journal of Haematology|October 23, 1997

Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cellsL Jia, R R Dourmashkin, P D Allen, et al.

Bone Marrow Transplantation|January 10, 2001

Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferonN C McBride, J D Cavenagh, A C Newland, et al.

Investigational New Drugs|January 1, 1997

Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphomaD S Richardson, S M Kelsey, S A Johnson, et al.

Cancer Research|March 4, 1998

1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2Y L Wu, X R Jiang, D M Lillington, et al.

British Medical Journal (Clinical Research Ed.)|February 12, 1983

Erythrapheresis in patients with polycythaemia secondary to hypoxic lung diseaseJ A Wedzicha, R M Rudd, M C Apps, et al.

Medical Oncology (Northwood, London, England)|December 15, 2000

Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotideM J Jenner, I N Micallef, A Z Rohatiner, et al.

Clinical Science (London, England : 1979)|October 1, 1985

Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemiaJ A Wedzicha, P M Cotes, D W Empey, et al.

Clinical Science (London, England : 1979)|January 1, 1986

Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonaleP J Wallis, J D Skehan, A C Newland, et al.

Pageof 24